PTCT Sale Disclosure
Boulding Mark Elliott · SEC Form 4 · Filed Oct 7, 2026
Sale
Calculated transaction value
$104.88K
Boulding Mark Elliott Exec. VP And CLO
PTCT
PTC Therapeutics
PTCT
Transaction date
Oct 5, 2026
Public filing date
Oct 7, 2026
Filing lag
Filed 2 days later
PTCT daily price context
Close on/before transaction
$63.65
Oct 5, 2026
First close after public filing
$62.56
Oct 8, 2026
Return after filing · so far
+3.42%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,638 shares @ $64.03
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001578852-26-000024
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$214.51K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ptc Therapeutics, Inc. PTCT | Exercise | Oct 6, 2026 | $0 |
| Ptc Therapeutics, Inc. PTCT | Sale | Oct 6, 2026 | $27.91K |
| Ptc Therapeutics, Inc. PTCT | Exercise | Oct 6, 2026 | $17.15K |
| Ptc Therapeutics, Inc. PTCT | Exercise | Oct 5, 2026 | $64.57K |
| Ptc Therapeutics, Inc. PTCT | Exercise | Oct 5, 2026 | $0 |
| Ptc Therapeutics, Inc. PTCT Current | Sale | Oct 5, 2026 | $104.88K |